N/A
N=132
Biomarkers in Thoracic Aorta Surgery
Aortic Aneurysm · Thoracoabdominal Aneurysm · Aortic Dissection · Complication
Bottom Line
View on ClinicalTrials.gov: NCT04689139 ↗Enrolled (actual)
132
Serious AEs
31.1%
Results posted
May 2024
Primary outcome: Primary: Number of Total Postoperative Complications — 69 post-operative complications
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- blood sample tests for determination of biomarkers levels (Diagnostic_test)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Petrovsky National Research Centre of Surgery
- Primary completion
- Feb 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Total Postoperative Complications |
69 | — |
| SECONDARY Total Number Affected by All-Cause Mortality |
2 | — |
| SECONDARY Number of Participants Who Require Extracorporeal Detoxication |
7 | — |
| SECONDARY Number of Cardiac Disorders |
16 | — |
| SECONDARY Number of Vascular Disorders |
14 | — |
| SECONDARY Number of Infections and Infestations |
36 | — |
Summary
Biomarkers can play a vital role in prognosing the perioperative complications in thoracic aorta surgery. The goal of a study is to determine the correlation between intraoperative level of certain biomarkers and total amount of peroperative complications.
Eligibility Criteria
Inclusion Criteria
- Elective thoracic and thoracoabdominal surgery
Exclusion Criteria
- Hemolysis in blood sample
Data sourced from ClinicalTrials.gov (NCT04689139). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.